Washington University School of Medicine

Digital Commons@Becker
2020-Current year OA Pubs

Open Access Publications

2-1-2021

A timely call to arms: COVID-19, the circadian clock, and critical
care
Jeffrey Haspel
Washington University School of Medicine in St. Louis

Minjee Kim
Northwestern University

Phyllis Zee
Northwestern University

Tanja Schwarzmeier
LMU Munich

Sara Montagnese
University of Padova

See next page for additional authors

Follow this and additional works at: https://digitalcommons.wustl.edu/oa_4
Part of the Medicine and Health Sciences Commons

Recommended Citation
Haspel, Jeffrey; Kim, Minjee; Zee, Phyllis; Schwarzmeier, Tanja; Montagnese, Sara; Panda, Satchidananda;
Albani, Adriana; and Merrow, Martha, "A timely call to arms: COVID-19, the circadian clock, and critical
care." Journal of biological rhythms. 36, 1. 55 - 70. (2021).
https://digitalcommons.wustl.edu/oa_4/186

This Open Access Publication is brought to you for free and open access by the Open Access Publications at
Digital Commons@Becker. It has been accepted for inclusion in 2020-Current year OA Pubs by an authorized
administrator of Digital Commons@Becker. For more information, please contact vanam@wustl.edu.

Authors
Jeffrey Haspel, Minjee Kim, Phyllis Zee, Tanja Schwarzmeier, Sara Montagnese, Satchidananda Panda,
Adriana Albani, and Martha Merrow

This open access publication is available at Digital Commons@Becker: https://digitalcommons.wustl.edu/oa_4/186

992587

research-article2021

JBRXXX10.1177/0748730421992587Journal of Biological RhythmsHaspel et al. / Short Title

REVIEW

A Timely Call to Arms: COVID-19, the Circadian
Clock, and Critical Care
Jeffrey Haspel*,1, Minjee Kim†, Phyllis Zee†, Tanja Schwarzmeier‡ , Sara Montagnese§ ,
Satchidananda Panda||, Adriana Albani‡,¶ and Martha Merrow‡,2
*
Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis,
Missouri, USA, †Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago,
Illinois, USA, ‡Institute of Medical Psychology, Faculty of Medicine, LMU Munich, Munich, Germany,
§
Department of Medicine, University of Padova, Padova, Italy, ||Salk Institute for Biological Studies, La Jolla,
California, USA, and ¶Department of Medicine IV, LMU Munich, Munich, Germany
Abstract We currently find ourselves in the midst of a global coronavirus disease 2019 (COVID-19) pandemic, caused by the highly infectious novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here,
we discuss aspects of SARS-CoV-2 biology and pathology and how these might
interact with the circadian clock of the host. We further focus on the severe
manifestation of the illness, leading to hospitalization in an intensive care unit.
The most common severe complications of COVID-19 relate to clock-regulated
human physiology. We speculate on how the pandemic might be used to gain
insights on the circadian clock but, more importantly, on how knowledge of the
circadian clock might be used to mitigate the disease expression and the clinical
course of COVID-19.
Keywords
rhythm
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Introduction
Coronavirus disease 2019 (COVID-19) is a new
pandemic respiratory illness with a highly variable
clinical presentation, ranging from asymptomatic
infection to profound respiratory and multiorgan failure (Wang et al., 2020b; Zhou et al., 2020a). With over
100 million people infected and 2 million fatalities,
COVID-19 ranks as one of the most lethal infectious
diseases in the year 2020 (World Health Organization,
2020). Amid enormous worldwide effort to stem this

disease much about the pathophysiology of COVID19 and its causative agent, severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2; Zhu et al.,
2020), remains to be clarified. Here and in the accompanying series of articles (Herz et al., 2021; KronfeldSchor et al., 2021; Sengupta et al., 2021), we discuss
potential contributions of the field of chronobiology
to the prevention, risk mitigation, prognosis, and
rehabilitation of critically ill COVID-19 patients. This
work is based on discussions at the European
Biological Rhythms Society–convened workshop on
Chronobiology and COVID-19 (Chronobiology of
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COVID-19 CARE Conference). Convened in July 2020,
this virtual workshop brought together 250 researchers and clinicians worldwide. They engaged in a
wide-ranging dialogue to consider how chronobiology and COVID-19 pathology might relate, what
kinds of model systems are needed, and how clinical
data might best be harnessed to explore such connections. Here, we provide a brief overview of COVID-19
with an emphasis on elements potentially sensitive to
circadian regulation based on the existing pre-COVID
literature. We conclude with a review of how critical
illness and the intensive care setting influence circadian output, which is relevant to patients with severe
COVID-19.

A Brief Overview of COVID-19
The causative agent of COVID-19, SARS-CoV-2, is
a novel beta-coronavirus that bears genetic and clinical resemblance to two prior endemic coronaviruses
of global concern: SARS, severe acute respiratory
syndrome, which appeared in 2002 and MERS,
Middle East respiratory syndrome, which appeared
in 2012 (Drosten et al., 2003; de Groot et al., 2013;
Haagmans et al., 2014; Coronaviridae Study Group of
the International Committee on Taxonomy of Viruses,
2020; Kim et al., 2020; Zhu et al., 2020). While all three
coronaviruses produce a similar picture of hypoxemic respiratory failure in humans with a 20%-70%
fatality rate once mechanical ventilation becomes
necessary (Yam et al., 2003; Alsolamy and Arabi, 2015;
Auld et al., 2020; Richardson et al., 2020), only SARSCoV-2 achieved pandemic spread. This may be
related to a greater ability of SARS-CoV-2 to productively replicate in the nasopharynx without inciting
symptoms of systemic illness that would otherwise
cause infected individuals to self-isolate (Wölfel et al.,
2020). Epidemiologic information about the scope of
asymptomatic spread remains incomplete due to the
lack of comprehensive virus testing in most countries
and a variable rate of false-negative tests. Among
symptomatic patients, roughly 81% experience mild
disease, 14% experience moderate symptoms requiring hospitalization, and 5% require hospitalization
plus advanced respiratory support in intensive care
units (ICUs; Huang et al., 2020; Richardson et al.,
2020; Yang et al., 2020). While prior chronic lung disease represents a potent risk factor for severe COVID19, most COVID-19 risk factors are extrapulmonary
in nature and include older age, obesity, hypertension, diabetes, and cardiovascular disease (Wang
et al., 2020a; Zheng et al., 2020).
SARS-CoV-2 infection begins in the upper respiratory tract with differentiated airway epithelial cells
being the initial sites of infection, particularly

multiciliated cells and secretory (club) cells (Hui
et al., 2020). Infection proceeds distally down the conducting airways to the alveolar space leading to the
infection of type I and type II pneumocytes as well as
alveolar macrophages (Grant et al., 2020; Hou et al.,
2020; Hui et al., 2020). While SARS-CoV-2 is cytopathic in immortalized cells, it is the host inflammatory response that is thought to be primarily
responsible for acute lung injury and breakdown of
alveolar architecture known as the acute respiratory
distress syndrome (ARDS; Thompson et al., 2017;
Bryce et al., 2020; Schaller et al., 2020). The advent of
ARDS frequently requires the initiation of mechanical ventilation to maintain life, but the elevated airway pressure this intervention imposes is itself
injurious and represents a second inflammatory “hit”
(Slutsky and Ranieri, 2013). If the host immune system succeeds in controlling the viral infection early,
ARDS lung pathology can fully resolve (Doglioni
et al., 2020). However, in some individuals, ARDS
lung pathology proceeds to a fibroproliferative stage
rendering lungs mechanically stiff, permanently
impairing ventilation, and unsustainably increasing
the work of breathing (Thompson et al., 2017).
Autopsy studies show that respiratory failure is usually the proximate cause of death due SARS-CoV-2,
although in critically ill patients, multisystem organ
dysfunction frequently occurs as well (Bryce et al.,
2020; Schaller et al., 2020; Wang et al., 2020b).
Two forms of systemic pathology bear special
mention in severe COVID-19. The first is macrophage
hyperactivation, leading to the elaboration of high
levels of circulating pro-inflammatory cytokines such
as interleukin 6 (IL-6; Moore and June, 2020). The
term “cytokine storm” has been applied to COVID19; however, it is unclear whether this condition is
unique to or even representative of most patients
with this disease (Lukan, 2020; Mudd et al., 2020).
Emerging evidence suggests that mechanically ventilated COVID-19 patients may have suppressed type I
interferon responses, suggesting a more complex picture than simple hypercytokinemia (GiamarellosBourboulis et al., 2020; Hadjadj et al., 2020; Mudd
et al., 2020). The second form of systemic pathology is
hypercoagulation, resulting in microthrombus formation and, somewhat counterintuitively, bleeding
(Al-Samkari et al., 2020; Bryce et al., 2020). While
sharing features with the more commonly known
disseminated intravascular coagulation (DIC),
COVID-induced hypercoagulability exhibits unique
aspects including preserved levels of circulating
fibrinogen and massively increased levels of von
Willebrand factor from activated or damaged endothelial cells (Ward et al., 2020; Zhang et al., 2020). The
clinical ramifications are that COVID-19 patients
have a dramatically increased risk of stroke,
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Figure 1. Life cycle of the SARS-CoV-2 virus. (a) Spike ( ), envelope, and matrix ( ) proteins are expressed on the surface of this
single-stranded RNA virus. Nucleocapsid protein binds and protects the genomic RNA (gRNA) until (b) the virus enters the cells via
spike protein interaction with cellular ACE2. (c) The gRNA of the positive-stranded RNA is transcribed and translated as a single
ORF, yielding the RTC. Structural proteins are transcribed subsequently from the (subgenomic, sg) 5’ end of the gRNA. (d) The RTC
integrates with the endoplasmic reticulum to form a double-membrane vesicle (DMV). (e) This structure produces virus which is
released. (f) Local viral load leads to the formation of multinucleated giant cells through the binding of spike and ACE2 proteins on
the surface of local cells. Abbreviations: SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2; ORF = open reading frame;
RTC = replicase-transcriptase complex; ACE2 = angiotensin-converting enzyme 2.

myocardial infarction, pulmonary and deep venous
thromboembolism, and major hemorrhage (Helms
et al., 2020b; Castro and Frishman, 2021). The mechanism underlying thrombosis in COVID-19 remains to
be clarified, although defects in platelet function were
recently described in patients (Iba et al., 2020; Zaid
et al., 2020).
The prognosis of COVID-19 largely depends on
the severity of respiratory failure. Patients with mild
to moderate disease appear to clinically recover
within 2 weeks, although viral RNA can be detected
in many patients for longer periods (Sun et al., 2020;
Wölfel et al., 2020). At present, patients who progress
to mechanical ventilation spend a median of 10-17
days intubated (Almeshari et al., 2020). The longterm recovery of severely ill COVID-19 patients has
yet to be charted, although reports of protracted
debility in the weeks following hospital discharge are
common (Lambert and Corps, 2020; Halpin et al.,
2021). In general, survival from critical illnesses is followed by protracted functional and cognitive impairment that persist even a year after hospital discharge
(Schelling et al., 1998; Bein et al., 2018).
Brief Overview of SARS-CoV-2
SARS-CoV-2 (Figure 1) is an enveloped singlestranded RNA virus that, typical of coronaviruses, is
distinguished morphologically by its spike (S)

protein which forms crown-like projections around
the viral particles on electron micrographs (Masters
and Perlman, 2013; Brahim Belhaouari et al., 2020).
There are three additional structural proteins in the
virion: the matrix (M) and envelope (E) proteins
which reside in the membrane, and the nucleocapsid
(N) protein that spools and protects the genomic
RNA (Masters and Perlman, 2013; Kim et al., 2020).
The S protein catalyzes viral entry and is thought to
be the main determinant of tissue and species tropism (Dinnon et al., 2020; Ou et al., 2020). It is a type
I transmembrane protein with a prominent extracellular region composed of two segments: an N-terminal
(S1) segment that engages cell-surface angiotensinconverting enzyme 2 (ACE2), and a C-terminal S2
segment that promotes trimerization and contains a
membrane fusion peptide (Cai et al., 2020; Ou et al.,
2020). The bioactivity of the fusion peptide is promoted by cleavage of the S protein, which is catalyzed
by extracellular proteases like TMPRSS2 or by lysosomal cathepsins (Hoffmann et al., 2020; Ou et al.,
2020).
The genome of SARS-CoV-2 consists of a single
positive-strand RNA roughly 30 kb in length that is
dominated by a single open reading frame (Orf1a/1b)
taking up two thirds of its length (Kim et al., 2020).
Orf1a/1b is translated off the genomic RNA as a single polypeptide that is autoproteolyzed into multiple
subunits forming the “Replicase-Transcriptase
Complex” (RTC; Kim et al., 2020). The RTC is believed
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to be responsible for all subsequent steps of viral replication (Masters and Perlman, 2013). The structural
proteins that comprise the viral capsid are expressed
later in infection as a series of subgenomic RNAs
(sgRNAs) that have a common 3’ end and sport an
identical leader sequence derived from the 5’ end of
the viral genome (Masters and Perlman, 2013; Kim
et al., 2020). The leader sequence allows for capping
and translation of all viral transcripts (Masters and
Perlman, 2013; Kim et al., 2020).
The next step in the SARS-CoV-2 replication
involves the establishment of a specialized organelle
in continuity with the endoplasmic reticulum (ER)
called a double-membrane vesicle (DMV) structure
(Klein et al., 2020). The DMV is thought to coordinate
viral replication and to sequester viral factors away
from innate immune sensors in the cytoplasm (Klein
et al., 2020). Of note, DMV membranes bear ultrastructural resemblance to autophagosome membranes, and autophagy markers are upregulated in
SARS-CoV-2–infected cells (Stukalov et al., 2020).
Viral RNA synthesis by coronaviruses generally
involves the production of a complementary negative-strand RNA template starting from the 3’ end of
the viral genome (Masters and Perlman, 2013; Kim
et al., 2020). Full-length templates are used for synthesis of progeny + RNA viral genomes, while the
shorter sgRNA templates drive the expression of the
four viral structural proteins plus accessory proteins
that may play a role in virus-host interactions
(Masters and Perlman, 2013; Liu et al., 2014). Rather
than engaging in RNA splicing, coronaviruses have a
unique method of ensuring inclusion of the genomic
5’ leader sequence in each sgRNA, which is essential
for translation. Directly upstream of the body of each
structural gene is a conserved “Transcription
Regulation Sequence” (TRS-B), which is identical to a
motif in the 5’ leader sequence (TRS-L). As the RTC
engages the negative-strand RNA synthesis, the polymerase can cross over from the TRS-B motif, located
upstream of the coding sequence in each nascent
sgRNA template, to the TRS-L sequence, thereby
appending the 5’ end of the genome to each RNA. As
a result, coronaviruses rely heavily on genetic recombination to complete its life cycle and have a proclivity for rapid viral evolution (Banner and Lai, 1991).
Reflecting this, the dominant SARS-CoV-2 genotype
appears to have changed with enhanced infectivity as
the virus spread from China to Europe and beyond
(Korber et al., 2020). Even in the same infected individual, SAR-CoV-2 genomes can vary based on the
anatomic location of sampling within the respiratory
system (Wölfel et al., 2020).
The final step in the SARS-CoV-2 life cycle is the
assembly and release of virions. For coronaviruses,
structural proteins of the viral envelope (the S, M,

and E proteins) are cotranslationally inserted into the
ER membrane and traffic to the ER-Golgi intermediate compartment (ERGIC; Masters and Perlman,
2013; Klein et al., 2020). There, nucleocapsids consisting of progeny genomes bound by N protein interact
with the envelope proteins and bud into the ERGIC
lumen. Virions are believed to reach the extracellular
space by bulk transport, although transport through
lysosomal compartments was recently suggested as
an alternative (Ghosh et al., 2020). A fraction of S protein reaches the plasma membrane, causing cell
fusion with neighboring infected cells and the formation of multinucleated giant cells that are characteristic of COVID-19 lung pathology (Masters and
Perlman, 2013; Bryce et al., 2020).
To summarize, SARS-CoV-2 engages infected hosts
at multiple levels during severe infection, inserting
itself into the host’s physiological processes, immune
responses, and fundamental cellular machineries. All
these layers of biological organization are influenced
by circadian rhythms, whose basic structure in mammals is summarized in the next section.
Relevant Features of Circadian Clock Organization
Circadian clocks impose a 24-h temporal structure
on more processes than we are able to count (Zhang
et al., 2014). In 1972, Arnold Eskin conceptualized circadian clocks as possessing an input pathway, an
oscillator and output pathway (Eskin, 1979). We now
know that this is an oversimplification of the system
(Roenneberg and Merrow, 1998; Duguay and
Cermakian, 2009; Ince et al., 2019; Reinke and Asher,
2019), but it remains a useful tool for conceptualization of circadian organization. The input pathway
processes zeitgeber signals. Zeitgebers are the regular, predictable signals emanating from the environment that organisms and cells use to synchronize to
time of day. For human behavior, light is the main
zeitgeber, acting via specialized retinal cells that
directly innervate the suprachiasmatic nuclei (SCN)
of the hypothalamus (the pacemaker for human
behavior). A well-known confounder of human synchronization is self-regulated and socially regulated
exposure to light such that the natural photic environment is not faithfully represented to the brain. We
do this by turning off the lights and closing our eyes
when we sleep as well as by living indoors and therefore changing the amplitude of the light/dark cycle
or, in extreme examples, by changing the timing of
our light environment due to shift work. The consequences of “living at the wrong time” (shift work) are
dire. Long-term shift workers have increased risks of
metabolic syndrome, coronary heart disease, and certain types of cancers (Schernhammer et al., 2001,
2003, 2006; Vetter et al., 2016). The phenomenon
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Table 1. Daily rhythms in expression of severe acute
respiratory syndrome coronavirus 2–relevant genes in tissues
isolated from baboons (Mure et al., 2018).
Gene

Tissue

BACE2 (BABOON ACE2)

Abdominal muscle

TMPRSS2

Omental fat

FURIN

Bladder
Cornea
Heart
Medial globus pallidus
Gastrocnemius muscle
Prefrontal cortex
Testicles
Thyroid
Ventromedial hypothalamus

Abbreviation: ACE2 = angiotensin-converting enzyme 2.

called social jetlag refers to the generally smaller shift
in timing due to the mismatch of social (e.g., school or
work) and biological clocks (Roenneberg et al., 2012).
Social jetlag is also characterized by behavioral and
physiological deficits. It is remarkable that even relatively short bouts of desynchrony can result in metabolic disturbance. After an experimental protocol
called forced desynchrony, whereby human subjects
are forced into a situation where they cannot synchronize to the short or long zeitgeber cycle, individuals
continue to show circa 24-h daily oscillations in physiology but prediabetic features become evident
(Scheer et al., 2009). A common consequence of controlled phase shifts, as occurs in transmeridian travel
or shift work, is decreased amplitude of the circadian
clock (Dijk et al., 2012).
In addition to synchronization of the organism as a
whole, each cell within us possesses a circadian clock.
Indeed, the organismal clock is built on individual
cellular circadian clocks. They respond to a cocktail of
endogenous zeitgebers for their synchronization.
Already in 2000, Basolobre et al. (2000b) showed that
cyclic adenosine monophosphate (cAMP) analogs,
dexamethasone, protein kinase C, and Ca2+ could
synchronize and phase shift clock gene oscillations in
Rat-1 fibroblasts. That this is relevant for human
entrainment and clock-regulated gene expression
was shown with administration of glucocorticoids
once a day, in the afternoon, resulting in reentrainment of clock gene expression in peripheral blood
mononuclear cells (PBMCs; Cuesta et al., 2015).
Importantly, the timing of nutrient uptake has
remarkable effects on the timing of clock gene expression in the liver. Experiments showed that the timing
or phase of rhythmic gene expression in peripheral
organs can resemble that of the SCN (entrained using
light) or that of the liver (entrained using food)

59

depending on the tissue and the relative strengths of
the zeitgebers (Stokkan et al., 2001). Cellular clocks
may be amplitude - attenuated by irregular zeitgeber
timing (Cuesta et al., 2015), as has been observed at
the organismal level, leading to a dysregulated circadian system. Obviously, entrainment or synchronization is a dominant feature of the circadian clock.
Concerning the oscillator mechanism, genetic data
show transcription factor networks toggling between
activation and repression to execute daily timing at
the molecular level (Aryal et al., 2017). As with all
other known transcription factors, the clock operates
in large multimeric protein complexes. This formula
creates many opportunities for fine tuning of daily
timing. Changes in the timing of transcription, translation, and posttranslational modifications of any of
the clock regulators, and changes in the temporal
structure of zeitgebers could result in fundamental
changes in characteristics of the oscillator and thus its
synchronization properties.
The output pathways are like the hands of a clock,
influencing clock-controlled regulation. Rhythmic
gene expression—beyond the transcription factors
thought to be at the center of the process—is generally tissue specific (Zhang et al., 2014). Historically,
there have been reports of some tissues lacking clockregulated gene expression, namely testis and thymus
(Alvarez and Sehgal, 2005). More recently, the baboon
transcriptome showed rhythms in these tissues (Mure
et al., 2018). It may be that all tissues show daily temporal structures at the molecular level. By extrapolation, we suggest that all tissues will exhibit functional,
tissue-specific circadian clock regulation.
Relevance of the Circadian Clock to SARS-CoV-2
Biology and Pathology
Is there any reason to connect rhythms to the disease process—from infection to pathology—associated with critically ill COVID-19 patients? One could
look at this from a level of the biology of the virus as
it leads to (different degrees of) pathology to how the
circadian clock may contribute to containment or
exacerbation of symptoms to considerations in the
clinical critical care environment. Any of these aspects
may lead to novel opportunities for interventions.
Concerning viral biology, are ACE2, TMPRSS2, and
FURIN clock regulated within cells? We interrogated
the database that describes gene expression in 64 tissues over 24 h in young, healthy, male baboons (Table
1; Mure et al., 2018). These genes are broadly expressed,
with BACE2 (the baboon ACE2 ortholog) and FURIN
giving a signal in all assayed tissues. TMPRSS2 is similarly broadly expressed except in the hippocampus,
the putamen, and the retina. Rhythmicity of RNA
expression corresponding to these genes, however,
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occurs seldomly. The gene for ACE2 is rhythmic only
in abdominal muscle. TMPRSS2 RNA is rhythmic
only in omental fat tissue. FURIN-encoding RNA was
rhythmic in nine tissues (bladder, cornea, heart, gastrocnemius muscle, testicles, thyroid, and three areas
of the brain). ACE2 gene expression measured in
homogenized mouse or human lung samples did not
exhibit rhythmic expression (Zhang et al., 2014; Ruben
et al., 2018). However, the lung has a high degree of
cellular diversity, consisting of more than 40 cell types
(Franks et al., 2008; Montoro et al., 2018; Reyfman
et al., 2019). It remains possible that ACE2 can be
rhythmically expressed in specific cells types, in
patients with inhaled exposures to irritants, or in the
setting of chronic lung diseases.
ACE2, angiotensin-converting enzyme 2, catalyzes
the hydrolysis of angiotensin 2 into angiotensin 1-7,
which has important anti-inflammatory properties
(Kuba et al., 2013). As a result, the relationship
between ACE2 levels and COVID-19 clinical severity
is more complex than it appears at first glance. For
example, ACE2 and angiotensin 1-7 levels tend to be
reduced in older individuals, a group that it is nevertheless at high risk for clinically severe COVID
(AlGhatrif et al., 2020; Miller et al., 2020). In this case,
whatever benefit might be gleaned by lower ACE2
levels on viral entry is apparently outweighed by the
magnification of host inflammatory responses that
result from the reduced amounts of angiotensin 1-7 in
older patients. While rhythmicity of ACE2 levels in
the lung has not yet been shown, ACE2 shows a diurnal variation in the blood (Veglio et al., 1987). RAS
has also been shown to influence the circadian clock
by modulating the expression of core clock genes
such as PER2 and BMAL1 (Nonaka et al., 2001).
Biological functions involved in viral processing
within cells (lysosomes, endocytic trafficking, and
various extracellular proteases) commonly exhibit
circadian oscillations in activity (Mazzoccoli et al.,
2015; Cuddapah et al., 2019; Chang et al., 2020). In
general, a single rhythmic rate-limiting step in viral
cell biology is sufficient to impose rhythmicity on the
entire process. Therefore, there are a number of possibilities that could lead to rhythms in in vivo viral
processing.
Concerning how the circadian clock may contribute
to exacerbation of pathology in critically ill patients
with COVID-19, several symptoms are particularly relevant. These patients may experience respiratory failure, microcoagulation events, and cytokine storm. The
molecular mechanisms involved in each of these are
regulated by the circadian clock. For instance, human
respiratory function shows clock regulation in mechanics (airway resistance and flow characteristics), ventilatory response to hypercapnia, and airway responses to
inhaled allergens (Shimoda and Semenza, 2011).

Concerning hypoxemic respiratory failure that can
occur in COVID-19, it is important to note that circadian clocks are sensitive to cellular oxygenation status
via the action of hypoxia inducible factor 1 alpha
(HIF1a; Adamovich et al., 2017; Peek et al., 2017). As
such, COVID-19 respiratory failure and its treatment
likely alter clock-regulated gene expression in the lung,
similar to what has been described in other acute lung
injuries (Jafri et al., 1992; Richardson Jones et al., 1996;
Bremner et al., 2000; Numminen et al., 2000). Regarding
the coagulation cascade, both clotting function and
clotting factors show complex time-of-day differences.
Several studies have demonstrated a diurnal rhythmicity in human platelet function (platelet counts and activation), endothelial function, and several coagulation
and fibrinolytic parameters (activated factor VII, factor
IX, beta-thromboglobulin, platelet factor 4, and fibrinogen; Rosing et al., 1970; Tofler et al., 1987; Akiyama
et al., 1990; Willich et al., 1992, 1993; Etsuda et al., 1999;
Ündar et al., 1999; Guagnano et al., 2000; Ringqvist
et al., 2000; Gaenzer et al., 2001; Osmancik et al., 2004;
Otto et al., 2004; Rudnicka et al., 2007). The circadian
clock has been shown to modulate both intrinsic and
extrinsic coagulation pathways, and the phase relations
of the rhythms of different coagulation parameters may
contribute to the known circadian variations in the frequency of arterial (e.g., myocardial infarction, sudden
cardiac death, cerebral infarction; Willich et al., 1993;
Montagnana et al., 2009) and venous (e.g., deep vein
thrombosis and pulmonary embolism) thromboembolic events as well as hemorrhagic phenomena (intracerebral hemorrhage, rupture of aortic aneurysms;
Maemura et al., 2006; Maas et al., 2020c).
With regard to the expression of cytokines, both
the transcription of cytokine-encoding genes as well
as stimulation of cytokine release show strong timeof-day regulation. Clock proteins are known to be
activators of some cytokines and suppressors of others (Timmons et al., 2020). Clock regulation occurs in
macrophages and monocytes (Figure 2) as well as for
T cells, thus impacting the immune responses of these
cells to pathogens (Scheiermann et al., 2018). It has
been suggested that mechanically ventilated COVID19 patients may have suppressed type I interferon
responses (Hadjadj et al., 2020). It is possible that a
misalignment here could influence the probability of
the occurrence of a cytokine storm. This aspect is discussed in the companion paper on the clock and the
immune system with respect to COVID-19.
COVID-19 and Chronopharmacology
The development of therapies to mitigate COVID-19
is an intense area of focus. Current therapies available
to critically ill patients include anti-inflammatory
drugs like glucocorticoids and tocilizumab, direct
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Figure 2. Circadian rhythms in critical illness. (a) Daily behavior and melatonin profiles in healthy individuals. (b) In intensive care
unit patients with neurological and systemic critical illness, behavioral rhythms are absent and melatonin rhythms show a variety of
changes depending on severity (as characterized by the Glasgow Coma Scale) and medication (the use of pressors or not). Data from
Maas et al. (2020c). (c) At the level of the lung, experiments in mice show expression of the PER2::LUC transgene (d) is delayed by approximately 4.5 h in hypoxic conditions. Data from Manella et al. (2020). (e) Peripheral blood mononuclear cells show rhythms of NR1D1 and
CRY1 gene expression (f) which are absent in cells from critically ill patients. Data from Maas et al. (2020a). (g) These same genes, NR1D1
and CRY1, show an 8-h difference in phase of expression in monocytes obtained from healthy human subjects. Data from Wittenbrink et
al. (2018). (h) We do not know what the status of molecular rhythms is in these cells in critically ill patients. Time is expressed as external
time (ExT), a convention that runs for 24 h starting at midnight (Daan et al., 2002).

antivirals like remdesivir, and SARS-CoV-2–
neutralizing antibodies conferred by convalescent
plasma. Whether time of day plays a role in the efficacy of these drugs in COVID-19 patients is unclear.
However, the pharmacokinetics and pharmacodynamics of many drugs are known to change over the
24 h. Accordingly, so do the efficacy and tolerance to
chemotherapy (Dallmann et al., 2016), and antibody
response to vaccination (Long et al., 2016). A recent
study has shown that approximately 50% of all currently used drugs target the product of a gene under
circadian control (Anafi et al., 2017). Finally, the outcomes of certain types of surgery (e.g., aortic valve
replacement; Montaigne et al., 2018) also vary across
time of day. Time of day differences may reflect the
time of maximum efficacy and success, or alternatively, the time of minimum adverse effects (Ballesta
et al., 2017).
Recently, a prospective meta-analysis from the
WHO Rapid Evidence Appraisal for COVID-19
Therapies (REACT) Working Group pooled data from
seven trials totaling 1703 patients and showed that
administration of systemic corticosteroids is associated with a lower 28-day mortality in critically ill
COVID-19 patients (Horby et al., 2020; Sterne et al.,
2020). Commonly known for their potent anti-inflammatory properties, glucocorticoids also act to synchronize the cellular circadian clock in most cells.
Interestingly, dexamethasone does not act on the SCN
clock, only on clocks in nonpacemaker cells (Balsalobre
et al., 2000a). Theoretically, glucocorticoid administration has the potential to synchronize peripheral clocks
in patients, although there are no studies demonstrating glucocorticoids can do this in the setting of critical

illness. Whether the salutary effects of glucocorticoids
on COVID-19 can be ascribed to circadian regulation
is unknown, but it represents a topic for future investigation. Another strong synchronizer of circadian
rhythms, melatonin, came to the attention of COVID19 researchers (Cardinali et al., 2020; Zhou et al.,
2020b). In a large registry of patients undergoing testing for suspected COVID-19, routine use of melatonin
was statistically associated with a negative COVID-19
quantitative polymerase chain reaction (qPCR) result,
suggesting melatonin might suppress SARS-CoV-2
replication (Zhou et al., 2020b). Melatonin is currently
under investigation as a potential SARS-CoV-2 antiviral therapy (Rodríguez-Rubio et al., 2020).
Implications of the Critical Care Environment and
the Circadian Clock on COVID-19
The potential effect of the ICU environment on a
patient’s circadian clock has been acknowledged for
years. This may be especially relevant in critically ill
COVID-19 patients who require a prolonged ICU
stay with limited exposure to normal environmental
zeitgebers. ICUs are well known to feature low, noncycling or weakly cycling light environments and
excessive noise due to equipment and alarms, conditions which disturb normal sleep (Boyko et al., 2017).
Furthermore, many patients are sedated due to various medical problems, interrupting behavioral control of light-dark cycles. In addition, feeding occurs
intravenously and continuously, rather than by more
physiological boluses. Various measures have confirmed that many ICU patients show either suppressed or inappropriately synchronized circadian
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rhythms. For example, Gazendem et al. (2013) showed
that the phase of the rhythm in core body temperature was displaced by more hours in sicker patients,
defined by a higher APACHE III score. A recent paper
confirmed this general finding but used heart rate
variability as a measure. Knauert et al. (2015) found
that most patients (>80%) showed daily rhythms but
that, already in the first 2 days in the ICU, the phase
of the rhythms was misaligned relative to a control
population. Based on these observations, we anticipate that many critically ill COVID-19 patients may
have circadian rhythms, but the entrained phase
(synchrony relative to the natural day) will not be
normal and it will be difficult to predict with current
information.
Certain severe illnesses may lead to disrupted circadian clock regulation independent of the environment. Patients with neurologic or systemic critical
illness have been shown to rapidly enter a state of
profound behavioral quiescence with the onset of illness, during which rest-activity rhythm showed
severe temporal disorganization and dissociation
from melatonin rhythms (Maas et al., 2020c).
Dampening of melatonin amplitude has been associated with worsening encephalopathy, although
improvement in encephalopathy was not associated
with corresponding change in melatonin amplitude
(Maas et al., 2020b). The altered oxygenation status in
the lung can shift the phase of clock gene expression
in the lung (Figure 2c and 2d; (Manella et al., 2020)).
Furthermore, circadian gene expression becomes
dampened in the ICU (Figure 2e and 2e; (Maas et al.,
2020a)). A key question remains with respect to the
state of the clock specifically in cells involved in acute
inflammation via production of cytokines, potentially
contributing to cytokine storm. Some of the highest
amplitude circadian rhythms described to date occur
in peritoneal macrophages (Keller et al., 2009). The
monocyte subset of PBMCs show distinct phase relationships between clock gene expression relative to
the whole blood cell population (Figure 2g vs 2e;
(Wittenbrink et al., 2018)). It is not known how these
cells function in critically ill patients or those in the
ICU (Figure 2h).
Interestingly, strong physiologic stressors can induce
a state of sleep-like behavioral quiescence in animal
models, which occurs in tandem with protective mechanisms to restore cellular homeostasis and recover from
cellular stress (Hill et al., 2014; Iannacone and Raizen,
2016; Nath et al., 2016; Trojanowski and Raizen, 2016).
During critical illness, normal sleep architectures on traditional electroencephalography (EEG) frequently disappear and are replaced with various abnormal patterns
that are neither sleep nor wake in a healthy state. It is
therefore difficult to apply traditional EEG scoring
methods for sleep and infer underlying sleep-associated

neurophysiologic processes to critically ill individuals
(Watson, 2007; Watson et al., 2013; Schabus et al., 2018;
Wislowska et al., 2018).
Nearly 30% of patients admitted to an ICU develop
delirium, which increases the mortality risk (Salluh
et al., 2015). Patients with COVID-19 are at increased
risk of delirium due to multiple factors, including (1)
direct central nervous system (CNS) invasion, (2)
induction of CNS inflammatory mediators, (3) secondary effect of noncerebral organ system failures,
(4) effect of sedative strategies, (5) prolonged mechanical ventilation, (6) immobilization, and (7) isolation
without family (Kotfis et al., 2020). Accordingly, a
high rate of delirium (up to 84%) has been reported in
critically ill patients with COVID-19 infection (Helms
et al., 2020a). Basic research suggests a link between
the circadian clock and delirium. In animal models,
constant light exposure, inflammation, and midazolam exposure can induce delirium-like phenotype
(i.e., impaired executive and memory function) and
reduced expression of PER2 in the SCN. This delirium-like phenotype was abolished by the PER2
enhancer nobiletin (Gile et al., 2018).
Although it is clear that the circadian clock is challenged in the ICU, the origin of circadian manifestations in critically ill patients cannot be definitively
attributed to the ICU environments. For example,
severe illnesses may have direct effects on the circadian clock, regardless of the ICU environments.
Furthermore, we have been operating with a bias that
an intact circadian system is always optimal. This is
partly due to observations of disruptions of metabolism with short-term clock disruption and increased
chronic pathologies with long-term disruption
(Schernhammer et al., 2001; Scheer et al., 2009). Stressinduced disruption of circadian rhythms or behavioral quiescence may rather represent a distinct
adaptive mechanism. If this is correct, then restoration of daily rhythms in physiologic variables may be
harmful. In other words, the “optimal state of biological rhythms” during critical illness may be different
from that in health.
Incorporation of the Circadian Clock Into Critical
Care Paradigms for Health and Knowledge
Discovering the State of the Circadian Clock in the
ICU. Chronobiologists are often biased to think that
the presence of a circadian rhythm is the preferred
state. Here, we have identified an ambiguous situation with a testable hypothesis. Our alternative
hypothesis is that supporting the circadian clock
with zeitgebers will lead to entrainment and daily
rhythms, and this in turn will lead to a better outcome. The null hypothesis would be that the presence of rhythms is an exacerbation and that the
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suppression of rhythms sometimes seen in serious
illness is adaptive. These hypotheses could be tested
descriptively via collection of continuous data from
ICU stations and analysis for rhythmicity and appropriate entrained phase as correlated with outcome.
The data routinely collected in the ICU—e.g., temperature, oxygen saturation, and heart rate—show
circadian rhythms in normal individuals. It represents a huge amount of information if it can be harnessed and analyzed. The hypotheses could also be
tested experimentally, for example, by examining
whether the circadian phase, amplitude, or robustness in temperature rhythms is associated with
patient outcomes from severe COVID-19.
Given that the mediators of the most common
complications in COVID-19 (hypercoagulation/
bleeding, cytokine storm) are extensively regulated
by the circadian clock, it may be expected that they
occur at discrete times of day. Understanding this
would allow for preventive treatments. Without
deeper knowledge of the endogenous circadian clock
characteristics specifically in the ICU, correct determination of clock regulation of these complications is
not possible. What is needed is a comprehensive atlas
of potential circadian outputs in ICU patients that
include minimally invasive measurements such as
blood pressure, heart rate, body temperature, as well
as serial peripheral blood sampling over at least two
cycles. From this dataset, ICU-appropriate biomarkers of the circadian clock can be derived to determine
the circadian profile of the patient (rhythmic/nonrhythmic, amplitude, phase) and to assess the internal time of greatest risk for complications and that of
optimal medication dosing schedules.
Delivering a Zeitgeber Cycle in the ICU. It can be challenging to administer a high-amplitude zeitgeber,
whether light/dark or administration of corticosteroids with a <24-h half-life, to sedated or septic
patients. Glucocorticoid administration should be
weighed against its potentially life-threatening side
effects including immunosuppression, and creating a
dark environment for the patient during the night
may interfere with patient care. On the other hand,
modifying timing of nutritional support is feasible in
the ICU for many patients and could potentially
entrain peripheral clocks. We know of no efforts to
administer food in the ICU intermittently, mimicking
normal eating behaviors, in sedated patients. How is
feeding accomplished in the ICU and what does
nutrition therapy look like? Clinical trials and guidelines on nutrition therapy during and after critical illness have largely focused on optimal timing (early vs
late initiation), route of delivery (gastric vs jejunal vs
parenteral), and caloric/protein target. Enteral nutrition (EN) is the preferred route of artificial nutrition
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therapy in critically ill patients. Initiation of nutrition
support therapy in the form of early EN within 24-48
h is recommended in the critically ill patient who is
unable to maintain volitional intake, unless there are
reasons to delay EN such as enteral obstruction,
active gastrointestinal bleeding, and compromised
splanchnic circulation (Taylor et al., 2016; Singer
et al., 2019).
Several methods of EN administration exist,
including continuous, cyclic, intermittent, and bolus
techniques. Continuous feeding involves hourly
administration of EN over 24 h assisted by a feeding
pump; cyclic feeding involves administration of EN
over a time period of <24 h generally assisted by a
feeding pump; intermittent feeding involves administration of EN over 20-60 min every 4-6 h via pump
assist or gravity assist; and bolus feeding involves
administration of EN over a 4- to 10-min period using
a syringe or gravity drip.
In practice, pump-assisted continuous feeding is
generally acceptable for critically ill patients to
reduce EN-related complications such as aspiration,
feeding intolerance/high gastric residual, underfeeding, and diarrhea. However, a limited number of
studies have been conducted to support this practice
(Hiebert et al., 1981; Kocan and Hickisch, 1986;
Ciocon et al., 1992; MacLeod et al., 2007). Small randomized controlled studies comparing bolus to continuous feeding in ventilated critically ill adults have
shown greater volume with fewer interruptions in
continuous feeding but no significant difference
between feeding techniques with regard to patient
outcome (Hiebert et al., 1981; Kocan and Hickisch,
1986; Ciocon et al., 1992; Bonten et al., 1996; Steevens
et al., 2002; MacLeod et al., 2007). Based on existing
evidence, the Society of Critical Care Medicine
(SCCM) and American Society for Parenteral and
Enteral Nutrition (ASPEN) suggest switching from
bolus to intermittent EN in cases of feeding intolerance, whereas European Society for Clinical Nutrition
and Metabolism (ESPEN) recommends continuous
rather than bolus EN (Grade B—strong consensus;
Taylor et al., 2016).
Time-restricted feeding (TRF) is an approach to
resetting biological rhythmicity via metabolic entrainment of peripheral tissues. It may be time to explore
the possibility of pursuing circadian realignment by
optimizing the timing of feeding in relation to daynight cycle for critically ill patients receiving EN
(Sunderram et al., 2014). Currently, no study has been
performed to investigate the effects of timing of feeding in either bolus or continuous feeding in the ICUs.
Future investigation will need to be equipped with a
thoughtful selection of potential biomarkers of rhythmicity in peripheral tissues that can be collected in
the clinical setting (e.g., microbiome, metabolomics/
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transcriptomics) and of clinically meaningful outcome variables.

Summary
Taken together there are numerous aspects of the
COVID-19 pandemic that may have a relationship to
circadian and other biological rhythms, ranging
from behavior of asymptotic carriers, organ physiology in the sick, the viral life cycle within infected
cells, and the host immune response. Although biologically plausible, there has been limited attention
to the potential protective effects of healthy sleep
and circadian rhythms. Interestingly, the consideration of the available data on the ICU environment
and critically ill patients points out the lack of data
demonstrating if and how sleep and a synchronized
clock contribute to healing. There are numerous
examples of circadian disruption leading to illness
but few examples of synchronization leading to
healing. With judicious collection of time-stamped
data, the current pandemic can be used to better
understand how the circadian clock is involved in
critical illness. We also propose that knowledge of
the state of the circadian clock may be used to mitigate all stages of COVID-19.
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